首页|介孔二氧化硅用于口服递送多肽和蛋白药物的研究进展

介孔二氧化硅用于口服递送多肽和蛋白药物的研究进展

扫码查看
多肽与蛋白质药物的口服递送近年来受到广泛关注,如何克服胃肠道生理屏障、提高生物利用度是其临床应用的关键问题.介孔二氧化硅是一种人工合成的纳米级无机多孔材料.介孔二氧化硅可调控的粒径、孔径、形态和表面化学的特性,使其具有作为口服递送多肽和蛋白质载体的潜力.文章综述了阻碍多肽与蛋白质药物口服吸收的主要屏障,介孔二氧化硅的特性、合成与表面修饰方法以及近年来取得的一些进展,以期为介孔二氧化硅用于口服递送多肽和蛋白药物提供新思路.
Research Progress on Mesoporous Silica for Oral Delivery of Peptide and Protein Drugs
The oral delivery of peptide and protein drugs has received widespread attention in recent years,and how to overcome gastrointestinal physiological barriers and improve bioavailability is a key issue in their clinical applications.Mesoporous silica is an artificially synthesized nanoscale inorganic porous material.Due to the unique properties,such as controllable particle size,pore size,morphology,and surface chemistry,mesoporous silica has the potential to serve as an oral delivery carrier for peptide and protein drugs.This article reviews the main barriers that hinder the oral absorption of peptides and protein drugs,the characteristics,synthesis,surface modification methods,and some recent advances of mesoporous silica,hoping to provide new ideas for the application of mesoporous silica to oral delivery of peptide and protein drugs.

polypeptideproteinmesoporous silicaoral administrationresearch progress

胡清源、芦晓红、高冬旭、何军

展开 >

中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203

多肽 蛋白质 介孔二氧化硅 口服给药 研究进展

2024

中国医药工业杂志
上海医药工业研究院,中国化学制药工业协会

中国医药工业杂志

CSTPCD
影响因子:0.487
ISSN:1001-8255
年,卷(期):2024.55(7)